Nuveen Asset Management Portfolio holdings
Nuveen Asset Management, founded in 1898 by John Nuveen and headquartered in Chicago, Illinois, is a leading global investment manager and subsidiary of TIAA, overseeing hundreds of billions in assets with a focus on fixed income, equities, and sustainable investing. Initially known for municipal bonds, Nuveen has expanded into a broad range of strategies, including mutual funds, ETFs, closed-end funds, and private capital solutions, serving institutional investors, financial advisors, and individuals. The firm emphasizes income-generating investments and ESG (environmental, social, governance) integration, leveraging its deep research capabilities and a century-long legacy in the bond market. With a strong presence in North America and growing international reach, Nuveen blends tradition with innovation to meet diverse client needs in the evolving investment landscape.
Top Buys
| 1 |
Amazon
AMZN
|
$767M |
| 2 |
Applied Materials
AMAT
|
$278M |
| 3 |
Kenvue
KVUE
|
$223M |
| 4 |
Salesforce
CRM
|
$217M |
| 5 |
S&P Global
SPGI
|
$214M |
Top Sells
| 1 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
$1.25B |
| 2 |
Advanced Micro Devices
AMD
|
$576M |
| 3 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
$446M |
| 4 |
Microsoft
MSFT
|
$341M |
| 5 |
Chubb
CB
|
$329M |
Sector Composition
| 1 | Technology | 27.91% |
| 2 | Healthcare | 12.64% |
| 3 | Financials | 11.26% |
| 4 | Consumer Discretionary | 11.01% |
| 5 | Industrials | 8.75% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
3201
Alto Ingredients
ALTO
$89M
| – | – |
-1,204,384
| Closed | -$1.81M |
|
3202
Aemetis
AMTX
$154M
| – | – |
-107,072
| Closed | -$248K |
|
3203
AN2 Therapeutics
ANTX
$34.4M
| – | – |
-15,546
| Closed | -$153K |
|
3204
American Public Education
APEI
$573M
| – | – |
-87,419
| Closed | -$474K |
|
3205
Grupo Aeroportuario del Sureste
ASR
$10.1B
| – | – |
-34,597
| Closed | -$10.6M |
|
3206
Aterian
ATER
$9.51M
| – | – |
-1,332
| Closed | -$14K |
|
3207
Athira Pharma
ATHA
$15.3M
| – | – |
-73,506
| Closed | -$184K |
|
3208
Altice USA
ATUS
$1.09B
| – | – |
-446,650
| Closed | -$1.53M |
|
3209
AXT Inc
AXTI
$137M
| – | – |
-116,103
| Closed | -$462K |
|
3210
Blend Labs
BLND
$947M
| – | – |
-128,384
| Closed | -$128K |
|
3211
Bionano Genomics
BNGO
$17M
| – | – |
-2,904
| Closed | -$1.93M |
|
3212
BioNTech
BNTX
$24.9B
| – | – |
-162,518
| Closed | -$20.2M |
|
3213
Brady Corp
BRC
$3.92B
| – | – |
-197,585
| Closed | -$10.6M |
|
3214
C4 Therapeutics
CCCC
$190M
| – | – |
-356,609
| Closed | -$1.12M |
|
3215
Celularity
CELU
$56.5M
| – | – |
-19,937
| Closed | -$124K |
|
3216
Cenntro
CENN
$27.1M
| – | – |
-51,200
| Closed | -$514K |
|
|
CISO
3217
CISO Global
CISO
$29.4M
| – | – |
-9,560
| Closed | -$49K |
|
3218
Clover Health Investments
CLOV
$1.38B
| – | – |
-1,041,822
| Closed | -$880K |
|
3219
Caesarstone
CSTE
$48M
| – | – |
-65,495
| Closed | -$271K |
|
3220
Citi Trends
CTRN
$321M
| – | – |
-100,848
| Closed | -$1.92M |
|
3221
China Yuchai International
CYD
$1.26B
| – | – |
-19,053
| Closed | -$150K |
|
3222
1stdibs.com
DIBS
$100M
| – | – |
-29,224
| Closed | -$116K |
|
3223
Erie Indemnity
ERIE
$17.6B
| – | – |
-59,205
| Closed | -$13.7M |
|
3224
Esperion Therapeutics
ESPR
$510M
| – | – |
-792,772
| Closed | -$1.26M |
|
3225
Ezcorp Inc
EZPW
$1.03B
| – | – |
-440,405
| Closed | -$3.79M |
|